{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T23:50:55Z","timestamp":1791244255609,"version":"4.1.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:00:00Z","timestamp":1773100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:00:00Z","timestamp":1773100800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1038\/s41431-026-02073-2","type":"journal-article","created":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T17:52:43Z","timestamp":1773165163000},"page":"1236-1242","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Validation structures for sequence variants of uncertain significance in hereditary cancer"],"prefix":"10.1038","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7654-9137","authenticated-orcid":false,"given":"Morghan C.","family":"Lucas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1693-4444","authenticated-orcid":false,"given":"Thomas","family":"Ke\u00dfler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Benet-Pag\u00e8s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5172-2818","authenticated-orcid":false,"given":"Elke","family":"Holinski-Feder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Laner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8753-8238","authenticated-orcid":false,"given":"Barbara","family":"Klink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,10]]},"reference":[{"key":"2073_CR1","doi-asserted-by":"publisher","first-page":"40","DOI":"10.5306\/wjco.v14.i2.40","volume":"14","author":"EN Imyanitov","year":"2023","unstructured":"Imyanitov EN, Kuligina ES, Sokolenko AP, Suspitsin EN, Yanus GA, Iyevleva AG, et al. Hereditary cancer syndromes. World J Clin Oncol. 2023;14:40\u201368.","journal-title":"World J Clin Oncol"},{"key":"2073_CR2","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s10689-018-0110-6","volume":"18","author":"JR Vos","year":"2019","unstructured":"Vos JR, Giepmans L, R\u00f6hl C, Geverink N, Hoogerbrugge N. ERN GENTURIS. Boosting care and knowledge about hereditary cancer: European Reference Network on Genetic Tumour Risk Syndromes. Fam Cancer. 2019;18:281\u20134.","journal-title":"Fam Cancer"},{"key":"2073_CR3","doi-asserted-by":"publisher","unstructured":"Idos GE, Kurian AW, Ricker C, Sturgeon D, Culver JO, Kingham KE, et al. Multicenter prospective cohort study of the diagnostic yield and patient experience of multiplex gene panel testing for hereditary cancer risk. JCO Precis Oncol. 2019. https:\/\/doi.org\/10.1200\/PO.18.00217.","DOI":"10.1200\/PO.18.00217"},{"key":"2073_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-022-01101-2","volume":"14","author":"O Ceyhan-Birsoy","year":"2022","unstructured":"Ceyhan-Birsoy O, Jayakumaran G, Kemel Y, Misyura M, Aypar U, Jairam S, et al. Diagnostic yield and clinical relevance of expanded genetic testing for cancer patients. Genome Med. 2022;14:92.","journal-title":"Genome Med"},{"key":"2073_CR5","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405.","journal-title":"Genet Med"},{"key":"2073_CR6","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.ajhg.2016.03.024","volume":"98","author":"LM Amendola","year":"2016","unstructured":"Amendola LM, Jarvik GP, Leo MC, McLaughlin HM, Akkari Y, Amaral MD, et al. Performance of ACMG-AMP variant-interpretation guidelines among nine laboratories in the Clinical Sequencing Exploratory Research consortium. Am J Hum Genet. 2016;98:1067\u201376.","journal-title":"Am J Hum Genet"},{"key":"2073_CR7","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/j.ajhg.2020.09.011","volume":"107","author":"LM Amendola","year":"2020","unstructured":"Amendola LM, Muenzen K, Biesecker LG, Bowling KM, Cooper GM, Dorschner MO, et al. Variant classification concordance using the ACMG-AMP variant interpretation guidelines across nine genomic implementation research studies. Am J Hum Genet. 2020;107:932\u201341.","journal-title":"Am J Hum Genet"},{"key":"2073_CR8","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1038\/gim.2017.14","volume":"19","author":"SM Harrison","year":"2017","unstructured":"Harrison SM, Dolinsky JS, Knight Johnson AE, Pesaran T, Azzariti DR, Bale S, et al. Clinical laboratories collaborate to resolve differences in variant interpretations submitted to ClinVar. Genet Med. 2017;19:1096\u2013104.","journal-title":"Genet Med"},{"key":"2073_CR9","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.ejmg.2017.07.016","volume":"60","author":"DF Vears","year":"2017","unstructured":"Vears DF, S\u00e9n\u00e9cal K, Borry P. Reporting practices for variants of uncertain significance from next generation sequencing technologies. Eur J Med Genet. 2017;60:553\u20138.","journal-title":"Eur J Med Genet"},{"key":"2073_CR10","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/gim.2016.152","volume":"19","author":"JM O\u2019Daniel","year":"2017","unstructured":"O\u2019Daniel JM, McLaughlin HM, Amendola LM, Bale SJ, Berg JS, Bick D, et al. A survey of current practices for genomic sequencing test interpretation and reporting processes in US laboratories. Genet Med. 2017;19:575\u201382.","journal-title":"Genet Med"},{"key":"2073_CR11","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/gim.2017.96","volume":"20","author":"JL Caswell-Jin","year":"2018","unstructured":"Caswell-Jin JL, Gupta T, Hall E, Petrovchich IM, Mills MA, Kingham KE, et al. Racial\/ethnic differences in multiple-gene sequencing results for hereditary cancer risk. Genet Med. 2018;20:234\u20139.","journal-title":"Genet Med"},{"key":"2073_CR12","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s10689-019-00144-6","volume":"18","author":"MK Ndugga-Kabuye","year":"2019","unstructured":"Ndugga-Kabuye MK, Issaka RB. Inequities in multi-gene hereditary cancer testing: lower diagnostic yield and higher VUS rate in individuals who identify as Hispanic, African or Asian and Pacific Islander as compared to European. Fam Cancer. 2019;18:465\u20139.","journal-title":"Fam Cancer"},{"key":"2073_CR13","doi-asserted-by":"publisher","first-page":"D862","DOI":"10.1093\/nar\/gkv1222","volume":"44","author":"MJ Landrum","year":"2016","unstructured":"Landrum MJ, Lee JM, Benson M, Brown G, Chao C, Chitipiralla S, et al. ClinVar: public archive of interpretations of clinically relevant variants. Nucleic Acids Res. 2016;44:D862\u20138.","journal-title":"Nucleic Acids Res"},{"key":"2073_CR14","doi-asserted-by":"publisher","first-page":"e1007752","DOI":"10.1371\/journal.pgen.1007752","volume":"14","author":"MS Cline","year":"2018","unstructured":"Cline MS, Liao RG, Parsons MT, Paten B, Alquaddoomi F, Antoniou A, et al. BRCA Challenge: BRCA Exchange as a global resource for variants in BRCA1 and BRCA2. PLoS Genet. 2018;14:e1007752.","journal-title":"PLoS Genet"},{"key":"2073_CR15","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1038\/s41431-021-00959-x","volume":"29","author":"IFAC Fokkema","year":"2021","unstructured":"Fokkema IFAC, Kroon M, L\u00f3pez Hern\u00e1ndez JA, Asscheman D, Lugtenburg I, Hoogenboom J, et al. The LOVD3 platform: efficient genome-wide sharing of genetic variants. Eur J Hum Genet. 2021;29:1796\u2013803.","journal-title":"Eur J Hum Genet"},{"key":"2073_CR16","doi-asserted-by":"publisher","first-page":"D1243","DOI":"10.1093\/nar\/gkae974","volume":"53","author":"G Perez","year":"2025","unstructured":"Perez G, Barber GP, Benet-Pages A, Casper J, Clawson H, Diekhans M, et al. The UCSC Genome Browser database: 2025 update. Nucleic Acids Res. 2025;53:D1243\u20139.","journal-title":"Nucleic Acids Res"},{"key":"2073_CR17","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/humu.21628","volume":"33","author":"AB Spurdle","year":"2012","unstructured":"Spurdle AB, Healey S, Devereau A, Hogervorst FBL, Monteiro ANA, Nathanson KL, et al. ENIGMA-evidence-based network for the interpretation of germline mutant alleles: an international initiative to evaluate risk and clinical significance associated with sequence variation in BRCA1 and BRCA2 genes. Hum Mutat. 2012;33:2\u20137.","journal-title":"Hum Mutat"},{"key":"2073_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.gimo.2024.101961","volume":"3","author":"A Benet-Pag\u00e8s","year":"2025","unstructured":"Benet-Pag\u00e8s A, Laner A, Nassar LR, Wohlfrom T, Steinke-Lange V, Haeussler M, et al. Reclassification of VUS in BRCA1 and BRCA2 using the new BRCA1\/BRCA2 ENIGMA track set demonstrates the superiority of ClinGen ENIGMA Expert Panel specifications over the standard ACMG\/AMP classification system. Genet Med Open. 2025;3:101961.","journal-title":"Genet Med Open"},{"key":"2073_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-019-0690-2","volume":"12","author":"SE Brnich","year":"2019","unstructured":"Brnich SE, Abou Tayoun AN, Couch FJ, Cutting GR, Greenblatt MS, Heinen CD, et al. Recommendations for application of the functional evidence PS3\/BS3 criterion using the ACMG\/AMP sequence variant interpretation framework. Genome Med. 2019;12:3.","journal-title":"Genome Med"},{"key":"2073_CR20","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1002\/humu.23650","volume":"39","author":"K Lee","year":"2018","unstructured":"Lee K, Krempely K, Roberts ME, Anderson MJ, Carneiro F, Chao E, et al. Specifications of the ACMG\/AMP variant curation guidelines for the analysis of germline CDH1 sequence variants. Hum Mutat. 2018;39:1553\u201368.","journal-title":"Hum Mutat"},{"key":"2073_CR21","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1136\/jmg-2022-108807","volume":"60","author":"X Luo","year":"2023","unstructured":"Luo X, Maciaszek JL, Thompson BA, Leong HS, Dixon K, Sousa S, et al. Optimising clinical care through CDH1-specific germline variant curation: improvement of clinical assertions and updated curation guidelines. J Med Genet. 2023;60:568\u201375.","journal-title":"J Med Genet"},{"key":"2073_CR22","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/ng.2854","volume":"46","author":"BA Thompson","year":"2014","unstructured":"Thompson BA, Spurdle AB, Plazzer JP, Greenblatt MS, Akagi K, Al-Mulla F, et al. Application of a 5-tiered scheme for standardized classification of 2,360 unique mismatch repair gene variants in the InSiGHT locus-specific database. Nat Genet. 2014;46:107\u201315.","journal-title":"Nat Genet"},{"key":"2073_CR23","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1016\/j.ajhg.2024.09.002","volume":"111","author":"X Yin","year":"2024","unstructured":"Yin X, Richardson M, Laner A, Shi X, Ognedal E, Vasta V, et al. Large-scale application of ClinGen-InSiGHT APC-specific ACMG\/AMP variant classification criteria leads to substantial reduction in VUS. Am J Hum Genet. 2024;111:2427\u201343.","journal-title":"Am J Hum Genet"},{"key":"2073_CR24","doi-asserted-by":"publisher","unstructured":"Sauer M, Lucas MC, Prokosch V, Ke\u00dfler T, Risch T, Laner A, et al. Improving genetic diagnosis of hereditary tumor syndromes: From expanded gene panels to functional genomics. Int J Cancer. 2025. https:\/\/doi.org\/10.1002\/ijc.70274.","DOI":"10.1002\/ijc.70274"},{"key":"2073_CR25","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s10689-025-00470-y","volume":"24","author":"MC Lucas","year":"2025","unstructured":"Lucas MC, Ke\u00dfler T, Scharf F, Steinke-Lange V, Klink B, Laner A, et al. A series of reviews in familial cancer: genetic cancer risk in context variants of uncertain significance in MMR genes: which procedures should be followed?. Fam Cancer. 2025;24:42.","journal-title":"Fam Cancer"},{"key":"2073_CR26","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41586-023-06045-0","volume":"625","author":"S Chen","year":"2024","unstructured":"Chen S, Francioli LC, Goodrich JK, Collins RL, Kanai M, Wang Q, et al. A genomic mutational constraint map using variation in 76,156 human genomes. Nature. 2024;625:92\u2013100.","journal-title":"Nature"},{"key":"2073_CR27","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.3389\/fgene.2019.01152","volume":"10","author":"G Marco-Puche","year":"2019","unstructured":"Marco-Puche G, Lois S, Ben\u00edtez J, Trivino JC. RNA-Seq perspectives to improve clinical diagnosis. Front Genet. 2019;10:1152.","journal-title":"Front Genet"},{"key":"2073_CR28","doi-asserted-by":"publisher","unstructured":"Horton C, Hoang L, Zimmermann H, Young C, Grzybowski J, Durda K, et al. Diagnostic outcomes of concurrent DNA and RNA sequencing in individuals undergoing hereditary cancer testing. JAMA Oncol. 2023;4. https:\/\/doi.org\/10.1001\/jamaoncol.2023.5586.","DOI":"10.1001\/jamaoncol.2023.5586"},{"key":"2073_CR29","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1002\/humu.24416","volume":"43","author":"D Smirnov","year":"2022","unstructured":"Smirnov D, Schlieben LD, Peymani F, Berutti R, Prokisch H. Guidelines for clinical interpretation of variant pathogenicity using RNA phenotypes. Hum Mutat. 2022;43:1056\u201370.","journal-title":"Hum Mutat"},{"key":"2073_CR30","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1136\/jmedgenet-2018-105606","volume":"56","author":"G Montalban","year":"2019","unstructured":"Montalban G, Bonache S, Moles-Fern\u00e1ndez A, Gisbert-Beamud A, Ten\u00e9s A, Bach V, et al. Screening of BRCA1\/2 deep intronic regions by targeted gene sequencing identifies the first germline BRCA1 variant causing pseudoexon activation in a patient with breast\/ovarian cancer. J Med Genet. 2019;56:63\u201374.","journal-title":"J Med Genet"},{"key":"2073_CR31","doi-asserted-by":"publisher","first-page":"e249580","DOI":"10.1136\/bcr-2022-249580","volume":"15","author":"K Fulk","year":"2022","unstructured":"Fulk K, Turner M, Eppolito A, Krukenberg R. RNA sequencing uncovers clinically actionable germline intronic MSH2 variants in previously unresolved Lynch syndrome families. BMJ Case Rep. 2022;15:e249580.","journal-title":"BMJ Case Rep"},{"key":"2073_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-020-0109-y","volume":"4","author":"T Landrith","year":"2020","unstructured":"Landrith T, Li B, Cass AA, Conner BR, LaDuca H, McKenna DB, et al. Splicing profile by capture RNA-seq identifies pathogenic germline variants in tumor suppressor genes. NPJ Precis Oncol. 2020;4:4.","journal-title":"NPJ Precis Oncol"},{"key":"2073_CR33","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1038\/s41436-018-0372-2","volume":"21","author":"M Drost","year":"2019","unstructured":"Drost M, Tiersma Y, Thompson BA, Frederiksen JH, Keijzers G, Glubb D, et al. A functional assay-based procedure to classify mismatch repair gene variants in Lynch syndrome. Genet Med. 2019;21:1486\u201396.","journal-title":"Genet Med"},{"key":"2073_CR34","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/s41436-019-0736-2","volume":"22","author":"M Drost","year":"2020","unstructured":"Drost M, Tiersma Y, Glubb D, Kathe S, van Hees S, Call\u00e9ja F, et al. Two integrated and highly predictive functional analysis-based procedures for the classification of MSH6 variants in Lynch syndrome. Genet Med. 2020;22:847\u201356.","journal-title":"Genet Med"},{"key":"2073_CR35","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1002\/humu.24387","volume":"43","author":"E Rayner","year":"2022","unstructured":"Rayner E, Tiersma Y, Fortuno C, van Hees-Stuivenberg S, Drost M, Thompson B, et al. Predictive functional assay-based classification of PMS2 variants in Lynch syndrome. Hum Mutat. 2022;43:1249\u201358.","journal-title":"Hum Mutat"},{"key":"2073_CR36","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ajhg.2020.12.003","volume":"108","author":"X Jia","year":"2021","unstructured":"Jia X, Burugula BB, Chen V, Lemons RM, Jayakody S, Maksutova M, et al. Massively parallel functional testing of MSH2 missense variants conferring Lynch syndrome risk. Am J Hum Genet. 2021;108:163\u201375.","journal-title":"Am J Hum Genet"},{"key":"2073_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-022-02839-z","volume":"23","author":"A Scott","year":"2022","unstructured":"Scott A, Hernandez F, Chamberlin A, Smith C, Karam R, Kitzman JO. Saturation-scale functional evidence supports clinical variant interpretation in Lynch syndrome. Genome Biol. 2022;23:266.","journal-title":"Genome Biol"},{"key":"2073_CR38","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41586-018-0461-z","volume":"562","author":"GM Findlay","year":"2018","unstructured":"Findlay GM, Daza RM, Martin B, Zhang MD, Leith AP, Gasperini M, et al. Accurate classification of BRCA1 variants with saturation genome editing. Nature. 2018;562:217\u201322.","journal-title":"Nature"},{"key":"2073_CR39","doi-asserted-by":"publisher","unstructured":"Dace P, Forrester NM, Zanti M, Cubitt L, Terwagne C, Buckley M, et al. Saturation genome editing of BRCA1 across cell types accurately resolves cancer risk. medRxiv. 2025. https:\/\/doi.org\/10.1101\/2025.08.11.25333423.","DOI":"10.1101\/2025.08.11.25333423"},{"key":"2073_CR40","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1038\/s41588-018-0122-z","volume":"50","author":"KA Matreyek","year":"2018","unstructured":"Matreyek KA, Starita LM, Stephany JJ, Martin B, Chiasson MA, Gray VE, et al. Multiplex assessment of protein variant abundance by massively parallel sequencing. Nat Genet. 2018;50:874\u201382.","journal-title":"Nat Genet"},{"key":"2073_CR41","doi-asserted-by":"publisher","first-page":"e1511207","DOI":"10.1080\/23723556.2018.1511207","volume":"5","author":"E Kotler","year":"2018","unstructured":"Kotler E, Segal E, Oren M. Functional characterization of the p53 \u201cmutome. Mol Cell Oncol. 2018;5:e1511207.","journal-title":"Mol Cell Oncol"},{"key":"2073_CR42","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1038\/s41588-018-0204-y","volume":"50","author":"AO Giacomelli","year":"2018","unstructured":"Giacomelli AO, Yang X, Lintner RE, McFarland JM, Duby M, Kim J, et al. Mutational processes shape the landscape of TP53 mutations in human cancer. Nat Genet. 2018;50:1381\u20137.","journal-title":"Nat Genet"},{"key":"2073_CR43","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/s41586-024-08388-8","volume":"638","author":"H Huang","year":"2025","unstructured":"Huang H, Hu C, Na J, Hart SN, Gnanaolivu RD, Abozaid M, et al. Functional evaluation and clinical classification of BRCA2 variants. Nature. 2025;638:528\u201337.","journal-title":"Nature"},{"key":"2073_CR44","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1053\/j.gastro.2019.03.071","volume":"157","author":"D Bouvet","year":"2019","unstructured":"Bouvet D, Bodo S, Munier A, Guillerm E, Bertrand R, Colas C, et al. Methylation tolerance-based functional assay to assess variants of unknown significance in the MLH1 and MSH2 genes and identify patients with Lynch syndrome. Gastroenterology. 2019;157:421\u201331.","journal-title":"Gastroenterology"},{"key":"2073_CR45","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1002\/humu.24462","volume":"43","author":"A Rath","year":"2022","unstructured":"Rath A, Radecki AA, Rahman K, Gilmore RB, Hudson JR, Cenci M, et al. A calibrated cell-based functional assay to aid classification of MLH1 DNA mismatch repair gene variants. Hum Mutat. 2022;43:2295\u2013307.","journal-title":"Hum Mutat"},{"key":"2073_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41379-018-0136-1","volume":"32","author":"W Chen","year":"2019","unstructured":"Chen W, Frankel WL. A practical guide to biomarkers for the evaluation of colorectal cancer. Mod Pathol. 2019;32:1\u201315.","journal-title":"Mod Pathol"},{"key":"2073_CR47","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/modpathol.2015.41","volume":"28","author":"TG Papathomas","year":"2015","unstructured":"Papathomas TG, Oudijk L, Persu A, Gill AJ, van Nederveen F, Tischler AS, et al. SDHB\/SDHA immunohistochemistry in pheochromocytomas and paragangliomas: a multicenter interobserver variation analysis using virtual microscopy: a Multinational Study of the European Network for the Study of Adrenal Tumors (ENS@T). Mod Pathol. 2015;28:807\u201321.","journal-title":"Mod Pathol"},{"key":"2073_CR48","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1136\/jclinpath-2019-206276","volume":"73","author":"LA Teixeira","year":"2020","unstructured":"Teixeira LA, Candido Dos Reis FJ. Immunohistochemistry for the detection of BRCA1 and BRCA2 proteins in patients with ovarian cancer: a systematic review. J Clin Pathol. 2020;73:191\u20136.","journal-title":"J Clin Pathol"},{"key":"2073_CR49","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1002\/humu.22213","volume":"34","author":"BA Thompson","year":"2013","unstructured":"Thompson BA, Goldgar DE, Paterson C, Clendenning M, Walters R, Arnold S, et al. A multifactorial likelihood model for MMR gene variant classification incorporating probabilities based on sequence bioinformatics and tumor characteristics: a report from the Colon Cancer Family Registry. Hum Mutat. 2013;34:200\u20139.","journal-title":"Hum Mutat"},{"key":"2073_CR50","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1016\/j.ajhg.2022.10.013","volume":"109","author":"V Pejaver","year":"2022","unstructured":"Pejaver V, Byrne AB, Feng BJ, Pagel KA, Mooney SD, Karchin R, et al. Calibration of computational tools for missense variant pathogenicity classification and ClinGen recommendations for PP3\/BP4 criteria. Am J Hum Genet. 2022;109:2163\u201377.","journal-title":"Am J Hum Genet"},{"key":"2073_CR51","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1038\/gim.2017.210","volume":"20","author":"SV Tavtigian","year":"2018","unstructured":"Tavtigian SV, Greenblatt MS, Harrison SM, Nussbaum RL, Prabhu SA, Boucher KM, et al. Modeling the ACMG\/AMP variant classification guidelines as a Bayesian classification framework. Genet Med. 2018;20:1054\u201360.","journal-title":"Genet Med"},{"key":"2073_CR52","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41586-021-04043-8","volume":"599","author":"J Frazer","year":"2021","unstructured":"Frazer J, Notin P, Dias M, Gomez A, Min JK, Brock K, et al. Disease variant prediction with deep generative models of evolutionary data. Nature. 2021;599:91\u20135.","journal-title":"Nature"},{"key":"2073_CR53","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.ajhg.2022.01.006","volume":"109","author":"M Quinodoz","year":"2022","unstructured":"Quinodoz M, Peter VG, Cisarova K, Royer-Bertrand B, Stenson PD, Cooper DN, et al. Analysis of missense variants in the human genome reveals widespread gene-specific clustering and improves prediction of pathogenicity. Am J Hum Genet. 2022;109:457\u201370.","journal-title":"Am J Hum Genet"},{"key":"2073_CR54","doi-asserted-by":"publisher","DOI":"10.1126\/science.adg7492","volume":"381","author":"J Cheng","year":"2023","unstructured":"Cheng J, Novati G, Pan J, Bycroft C, \u017demgulyt\u0117 A, Applebaum T, et al. Accurate proteome-wide missense variant effect prediction with AlphaMissense. Science. 2023;381:eadg7492.","journal-title":"Science"},{"key":"2073_CR55","doi-asserted-by":"publisher","first-page":"D941","DOI":"10.1093\/nar\/gky1015","volume":"47","author":"JG Tate","year":"2019","unstructured":"Tate JG, Bamford S, Jubb HC, Sondka Z, Beare DM, Bindal N, et al. COSMIC: the catalogue of somatic mutations in cancer. Nucleic Acids Res. 2019;47:D941\u20137.","journal-title":"Nucleic Acids Res"},{"key":"2073_CR56","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/nbt.3391","volume":"34","author":"MT Chang","year":"2016","unstructured":"Chang MT, Asthana S, Gao SP, Lee BH, Chapman JS, Kandoth C, et al. Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity. Nat Biotechnol. 2016;34:155\u201363.","journal-title":"Nat Biotechnol"},{"key":"2073_CR57","unstructured":"UniProt Consortium. UniProt: The universal protein knowledgebase in 2025. Nucleic Acids Res. 2025;53:D609\u201317."},{"key":"2073_CR58","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.cell.2018.12.015","volume":"176","author":"K Jaganathan","year":"2019","unstructured":"Jaganathan K, Kyriazopoulou Panagiotopoulou S, McRae JF, Darbandi SF, Knowles D, Li YI, et al. Predicting splicing from primary sequence with deep learning. Cell. 2019;176:535\u201348.e24.","journal-title":"Cell"},{"key":"2073_CR59","doi-asserted-by":"crossref","unstructured":"Canson DM, Davidson AL, de la Hoya M, Parsons MT, Glubb DM, Kondrashova O, et al. SpliceAI-10k calculator for the prediction of pseudoexonization, intron retention, and exon deletion. Bioinformatics. 2023;39:btad179.","DOI":"10.1093\/bioinformatics\/btad179"},{"key":"2073_CR60","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/s41588-023-01373-3","volume":"55","author":"N Wagner","year":"2023","unstructured":"Wagner N, \u00c7elik MH, H\u00f6lzlwimmer FR, Mertes C, Prokisch H, Y\u00e9pez VA, et al. Aberrant splicing prediction across human tissues. Nat Genet. 2023;55:861\u201370.","journal-title":"Nat Genet"},{"key":"2073_CR61","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.gim.2021.09.001","volume":"24","author":"AM Bournazos","year":"2022","unstructured":"Bournazos AM, Riley LG, Bommireddipalli S, Ades L, Akesson LS, Al-Shinnag M, et al. Standardized practices for RNA diagnostics using clinically accessible specimens reclassifies 75% of putative splicing variants. Genet Med. 2022;24:130\u201345.","journal-title":"Genet Med"},{"key":"2073_CR62","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1101\/gr.231100.117","volume":"28","author":"M Nattestad","year":"2018","unstructured":"Nattestad M, Goodwin S, Ng K, Baslan T, Sedlazeck FJ, Rescheneder P, et al. Complex rearrangements and oncogene amplifications revealed by long-read DNA and RNA sequencing of a breast cancer cell line. Genome Res. 2018;28:1126\u201335.","journal-title":"Genome Res"},{"key":"2073_CR63","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1038\/s41436-020-0880-8","volume":"22","author":"ML Thibodeau","year":"2020","unstructured":"Thibodeau ML, O\u2019Neill K, Dixon K, Reisle C, Mungall KL, Krzywinski M, et al. Improved structural variant interpretation for hereditary cancer susceptibility using long-read sequencing. Genet Med. 2020;22:1892\u20137.","journal-title":"Genet Med"},{"key":"2073_CR64","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1136\/jmg-2023-109155","volume":"60","author":"M Filser","year":"2023","unstructured":"Filser M, Schwartz M, Merchadou K, Hamza A, Villy MC, Decees A, et al. Adaptive nanopore sequencing to determine pathogenicity of BRCA1 exonic duplication. J Med Genet. 2023;60:1206\u20139.","journal-title":"J Med Genet"},{"key":"2073_CR65","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/s41431-023-01494-7","volume":"32","author":"PM Bj\u00f8rnstad","year":"2024","unstructured":"Bj\u00f8rnstad PM, Aal\u00f8kken R, \u00c5sheim J, Sundaram AYM, Felde CN, \u00d8stby GH, et al. A 39 kb structural variant causing Lynch Syndrome detected by optical genome mapping and nanopore sequencing. Eur J Hum Genet. 2024;32:513\u201320.","journal-title":"Eur J Hum Genet"},{"key":"2073_CR66","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1101\/gr.260497.119","volume":"30","author":"S Aganezov","year":"2020","unstructured":"Aganezov S, Goodwin S, Sherman RM, Sedlazeck FJ, Arun G, Bhatia S, et al. Comprehensive analysis of structural variants in breast cancer genomes using single-molecule sequencing. Genome Res. 2020;30:1258\u201373.","journal-title":"Genome Res"},{"key":"2073_CR67","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1101\/gr.279158.124","volume":"34","author":"S Gulsuner","year":"2024","unstructured":"Gulsuner S, AbuRayyan A, Mandell JB, Lee MK, Bernier GV, Norquist BM, et al. Long-read DNA and cDNA sequencing identify cancer-predisposing deep intronic variation in tumor-suppressor genes. Genome Res. 2024;34:1825\u201331.","journal-title":"Genome Res"},{"key":"2073_CR68","doi-asserted-by":"crossref","unstructured":"Lucas MC, Novoa EM. Long-read sequencing in the era of epigenomics and epitranscriptomics. Nat Methods. 2023;20:25\u201329.","DOI":"10.1038\/s41592-022-01724-8"},{"key":"2073_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.xgen.2024.100674","volume":"4","author":"K O\u2019Neill","year":"2024","unstructured":"O\u2019Neill K, Pleasance E, Fan J, Akbari V, Chang G, Dixon K, et al. Long-read sequencing of an advanced cancer cohort resolves rearrangements, unravels haplotypes, and reveals methylation landscapes. Cell Genom. 2024;4:100674.","journal-title":"Cell Genom"},{"key":"2073_CR70","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/s41431-023-01532-4","volume":"32","author":"Z Fehlberg","year":"2024","unstructured":"Fehlberg Z, Stark Z, Best S. Reanalysis of genomic data, how do we do it now and what if we automate it? A qualitative study. Eur J Hum Genet. 2024;32:521\u20138.","journal-title":"Eur J Hum Genet"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41431-026-02073-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-026-02073-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-026-02073-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T12:15:32Z","timestamp":1788783332000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41431-026-02073-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,10]]},"references-count":70,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["2073"],"URL":"https:\/\/doi.org\/10.1038\/s41431-026-02073-2","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,10]]},"assertion":[{"value":"14 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}